FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News

Links shared publicly online about this topic.

1,819
total visits

FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News

The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.

View full resource at news.psydir.com

Tags: Bipolar Disorder, Schizophrenia, Psychotic Disorder, Disease and Condition, Diet and Nutrition, FDA, News